Dual actionability of BMI1 activation and mitotic vulnerability defines adaptive Osimertinib resistance in EGFR-mutant NSCLCPaolo Armanetti, Giorgia Maroni, Elena Levantini et al.|Cell Death and Disease|2026Cited by 1